Catalyst Event
JD Health International Inc (6618) · Other
From Akros SCHK HK-Global High Beta Factor Index (ASHGHBT)
3/29/2026, 12:00:00 AM
Announced a deepened cooperation agreement with Shouer Pharmaceutical on March 29, 2026, to enhance the accessibility of children's medicines and health products by leveraging JD Health's digital platform and supply chain; low importance reflects a typical strategic partnership with an estimated ≥1% price impact, scheduled.
Korean Translation
2026년 3월 29일, 서우얼제약(Shouer Pharmaceutical)과의 협력 심화 계약을 발표함. 징동건강의 디지털 플랫포과 공급망을 활용하여 아동용 의약품 접근성을 높일 예정임. 일반적인 전략적 제휴로 1% 이상의 주가 영향이 예상되어 중요도를 'Low'로 설정하였으며, 해당 일정은 예정됨.
Related Recent Events
AIA Group Ltd (1299) · Other
Ex-dividend date for the 2025 final dividend of 144.08 Hong Kong cents per share, which was announced on March 19, 2026, is scheduled for May 28, 2026. Low importance is estimated as ex-dividend adjustments typically impact price by 1-2%, scheduled.
5/28/2026, 12:00:00 AM
Tencent Holdings LTD (700) · Other
Tencent's final dividend of HKD 5.30 per share for fiscal year 2025 with the ex-dividend date on May 15, 2026, is estimated to have a medium price impact of over 5% and is scheduled.
5/15/2026, 12:00:00 AM
Hong Kong Exchanges and Clearing Ltd (388) · Earnings Release
First quarter 2026 earnings results are scheduled to be released on April 29, 2026. The release is estimated to have a price impact of ~5%, scheduled.
4/29/2026, 12:00:00 AM
NXP Semiconductors NV (NXPI) · Earnings Release
NXP Semiconductors is scheduled to release its financial results for the first quarter of 2026 after the market close on April 28, 2026, scheduled. High importance is assigned as earnings releases typically cause significant price volatility exceeding 10%.
4/28/2026, 12:00:00 AM
Tesla Inc (TSLA) · Earnings Release
Tesla's Q1 2026 earnings release, with low importance estimated based on typical quarterly price volatility, is scheduled.
4/22/2026, 12:00:00 AM
Ubtech Robotics Corp Ltd (9880) · Earnings Release
The board of directors is scheduled to meet on March 31, 2026, to approve the annual results for the year ended December 31, 2025, and consider the payment of a final dividend, with the full earnings report expected. High importance is estimated due to the potential for a price impact of 10% or more, expected.
3/31/2026, 12:00:00 AM